Childhood granulomatous periorificial dermatitis

From WikiMD's Medical Encyclopedia

Revision as of 22:55, 3 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Childhood granulomatous periorificial dermatitis
Synonyms Facial Afro-Caribbean childhood eruption (FACE)
Pronounce N/A
Specialty N/A
Symptoms Papular rash around the mouth, nose, and eyes
Complications Possible scarring
Onset Childhood
Duration Chronic
Types N/A
Causes Unknown
Risks More common in Afro-Caribbean children
Diagnosis Clinical
Differential diagnosis Perioral dermatitis, Sarcoidosis, Granulomatous rosacea
Prevention N/A
Treatment Topical antibiotics, Topical corticosteroids
Medication Metronidazole, Erythromycin
Prognosis N/A
Frequency Rare
Deaths N/A


A rare skin condition affecting children


Childhood granulomatous periorificial dermatitis (CGPD) is a rare dermatological condition that primarily affects children. It is characterized by the presence of papular eruptions around the orifices of the face, such as the mouth, nose, and eyes. This condition is also known as facial Afro-Caribbean childhood eruption (FACE) due to its higher prevalence in children of African descent.

Clinical Presentation[edit]

CGPD typically presents as small, flesh-colored to erythematous papules that are symmetrically distributed around the periorificial areas of the face. These papules may coalesce to form plaques. The condition is usually asymptomatic, although some patients may experience mild itching or burning sensations.

Etiology[edit]

The exact cause of CGPD is unknown. However, it is believed to be a variant of perioral dermatitis, with potential contributing factors including the use of topical corticosteroids, exposure to certain environmental factors, and genetic predisposition. The condition is more commonly observed in children with darker skin types.

Diagnosis[edit]

The diagnosis of CGPD is primarily clinical, based on the characteristic appearance and distribution of the lesions. A skin biopsy may be performed to confirm the diagnosis, revealing granulomatous inflammation in the dermis. Differential diagnoses include sarcoidosis, lupus miliaris disseminatus faciei, and granulomatous rosacea.

Management[edit]

Treatment of CGPD involves the discontinuation of any topical corticosteroids and the use of topical or oral antibiotics, such as metronidazole or erythromycin. In some cases, topical calcineurin inhibitors like tacrolimus may be effective. The condition often resolves spontaneously over time, but treatment can help accelerate the resolution of lesions.

Prognosis[edit]

The prognosis for CGPD is generally good, with most cases resolving without significant scarring or complications. However, the condition may persist for several months to years before complete resolution.

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.